STEPHANIE SCHATZ: Open Payments
NPI 1255748349 · SULLIVAN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,062 in 77 payments from 21 companies in 2025. Trend: 2023 $1,142 · 2024 $1,043 · 2025 $1,062
Food & beverage: $1,062
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $286 |
| Amgen Inc. | 18 | $202 |
| Radius Health, Inc. | 2 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Novo Nordisk Inc | 2 | $41 |
| Viatris Specialty LLC | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
| Exact Sciences Corporation | 2 | $31 |
Products named: OTEZLA, VRAYLAR, QULIPTA, REXULTI, UBRELVY, Tymlos, Ozempic, YUPELRI.
Industry payments across MO — which companies pay providers there.
